Project Details
Description
Phaes II, Multicenter, Open-Label, Single Arm Trial to Evaluate the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refratory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
| Status | Finished |
|---|---|
| Effective start/end date | 7/31/08 → 12/31/10 |
Funding
- EISAI MEDICAL RESEARCH INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.